PT  - JOURNAL ARTICLE
AU  - Koh, Kwang Kon
TI  - Multiple Targeted Therapy is Critical for Reducing Cardiometabolic Risk
DP  - 2011 Jun 01
TA  - MD Conference Express
PG  - 16--17
VI  - 11
IP  - 2
4099  - http://mdc.sagepub.com/content/11/2/16.short
4100  - http://mdc.sagepub.com/content/11/2/16.full
AB  - Obesity is associated with a range of adverse metabolic consequences, including endothelial dysfunction, systemic inflammation, and insulin resistance. Therefore, to provide effective protection against the development of atherosclerosis and heart disease, obese patients require combination drug regimens that target several cardiometabolic risk factors.